Viewing Study NCT02200718


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2026-03-02 @ 11:39 PM
Study NCT ID: NCT02200718
Status: UNKNOWN
Last Update Posted: 2020-03-31
First Post: 2014-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis
Sponsor: Immune Response BioPharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Sclerosis Pediatric MS NeuroVax Vaccine Therapeutic View